GAS5 and Disorder of lipid metabolism: This effect entails downregulation of peroxisome proliferator-activated receptor α (PPARα) and upregulation of carnitine palmitoyltransferase 1 (CPT1), indicating that lncRNA GAS5 knockdown curtails both lipid metabolic disorders and inflammation [56].